Evidence map›Paper›PMID 17462731›Full record

ArticleLeukemia research2008

Guanine nucleotide depletion inhibits pre-ribosomal RNA synthesis and causes nucleolar disruption.

Min Huang, Yanshan Ji, Koji Itahana, Yanping Zhang, Beverly Mitchell

Abstract read
In one paragraph

Article in Leukemia research, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 56 citations in OpenAlex.

  1. Trial
  2. ExploringAntimicrobial agents and chemotherapy · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. The Evolution of the Ribosomal Protein-MDM2-p53 Pathway.Cold Spring Harbor perspectives in medicine · 2016
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Min HuangDepartment of Medicine, Division of Oncology, Stanford University, Stanford, CA 94305-5796, USA.
Yanshan Ji
Koji Itahana
Yanping Zhang
Beverly Mitchell
University of North Carolina at Chapel Hill · USStanford University · US

Funding

Regulation of MDM2 by the ribosomal protein L11R01CA100302 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI ZHANG, YANPING · 2003 to 2013
$3.2M
Inosine Monophosphate Dehydrogenase: Regulation/FunctionR01CA064192 · NCI · UNIVERSITY OF NORTH CAROLINA CHAPEL HILL · PI MITCHELL, BEVERLY SHRIVER · 1994 to 2007
$2.3M
ARF MDM2 P53 TUMOR SUPPRESSION PATHWAYK01CA087580 · NCI · UNIVERSITY OF TEXAS MD ANDERSON CAN CTR · PI ZHANG, YANPING · 2000 to 2005
$673k
NCI NIH HHS 5R01-CA064192NCI NIH HHS K01 CA087580NCI NIH HHS R01 CA064192NCI NIH HHS R01 CA100302
6 · The paper itself

Abstract

Inosine monophosphate dehydrogenase (IMPDH) is a pivotal enzyme in the de novo pathway of guanine nucleotide biosynthesis. Inhibitors of this enzyme decrease intracellular guanine nucleotide levels by 50-80% and have potential as anti-neoplastic agents. Both mycophenolic acid (MPA) and AVN-944 are highly specific inhibitors of IMPDH that cause cell cycle arrest or apoptosis in lymphocytes and leukemic cell lines. We have examined the mechanisms by which these two agents cause cytotoxicity. Both MPA and AVN-944 inhibit the growth of K562 cells, and induce apoptosis in Raji B and CCRF-CEM T cells. Both compounds strikingly inhibit RNA synthesis within 2 h of exposure. Depletion of guanine nucleotides by MPA and AVN-944 also causes an early and near-complete reduction in levels of the 45S precursor rRNA synthesis and the concomitant translocation of nucleolar proteins including nucleolin, nucleophosmin, and nucleostemin from the nucleolus to the nucleoplasm. This efflux correlates temporally with the sustained induction of p53 in cell lines with wild-type p53. We conclude that inhibition of IMPDH causes a primary reduction in rRNA synthesis and secondary nucleolar disruption and efflux of nucleolar proteins that most likely mediate cell cycle arrest or apoptosis. The ability of AVN-944 to induce apoptosis in a number of leukemic cell lines supports its potential utility in the treatment of hematologic malignancies.

Indexed as

AnimalsCarbamatesCell Line, TumorCell NucleolusCell ProliferationCell SurvivalGene Expression RegulationGenes, p53Guanine NucleotidesHumansIMP DehydrogenaseK562 CellsMiceMycophenolic AcidPhenylurea CompoundsReverse Transcriptase Polymerase Chain ReactionAVN 944CarbamatesGuanine NucleotidesIMP DehydrogenaseMycophenolic AcidPhenylurea CompoundsRNA PrecursorsRNA, Ribosomal

Identifiers

PMID17462731
PMCPMC4552191
OpenAlexW1969689238

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.